Pediatric Mitral Valve Insufficiency
- Author: Monesha Gupta, MD, MBBS, FAAP, FACC, FASE; Chief Editor: Stuart Berger, MD more...
Background
Mitral regurgitation (MR) occurs when the mitral valve allows reversal of blood flow from the left ventricle (LV) to the left atrium.[1]
The presentation of mitral regurgitation varies and largely depends on etiology, severity, and rate of onset. In acute severe mitral regurgitation, the patient may present in heart failure or cardiogenic shock. In chronic mitral regurgitation, depending on the degree of regurgitation, patients may be asymptomatic and may remain so for many years. As the volume of regurgitation increases, the LV also increases in size. Progressive LV dilation eventually leads to impaired contraction, increased afterload, reduced cardiac output, and, finally, left heart failure. Major factors in management include determining when to start therapy and what kind of intervention is needed. Prognosis in patients with mitral regurgitation varies with the timing of presentation and the severity of associated congenital defects.
Embryology and anatomy
Formation of the atrioventricular valve is completed early in embryologic development. The mitral valve is formed from endocardial cushions that originate both at the atrioventricular orifice and from muscular tissue of the ventricular wall. This process creates the 4 major components of the mitral valve, which are the mitral annulus, the mitral leaflets, the chordae tendineae, and the papillary muscles.[2]
The mitral annulus is derived from the fibrous skeleton of the heart, which is discontinuous posteriorly, thus increasing risk for posterior annular dilatation. The mitral valve leaflets (anterior and posterior) consist of collagenous fibrosa and spongiosa peripherally and mucoid myxomatous tissue centrally. The anterior leaflet is one third of the mitral valve and attaches to the mitral annulus, whereas the posterior leaflet attaches to the posterior lateral free wall of the LV. The chordae tendineae are a complex network of collagenous cordlike structures that extend from the free edges of the mitral valve leaflets to the papillary muscles. These papillary muscles arise from the ventricular wall. Two papillary muscles arise from ventricular free wall. Hence, ventricular geometry can effect the function of the papillary muscles.
These 4 anatomic components function to allow unobstructed blood flow from the left atrium to the LV during diastole and to maintain competent closure during systole. The leaflets open fully during the early rapid-filling phase of diastole. They begin to close passively as LV pressure and volume increase. Then, the leaflets reopen briefly as atrial contraction occurs, adding additional volume to the LV. During atrial contraction, annular contraction begins, effectively decreasing the circumference of the mitral valve by 20-30% throughout systole. Contraction of the papillary muscles serves to maintain the length of the chordae under the pressure that develops during systole. In the event that one or more of the 4 components is rendered nonfunctional or developmentally abnormal, mitral regurgitation results.
Pathophysiology
Normal blood flow from the left atrium to the LV and, subsequently, to the systemic circulation, is altered in mitral regurgitation. In the presence of mitral regurgitation, blood flows antegrade from the LV into the aorta, and the regurgitant volume flows retrograde from the LV into the left atrium. This causes a proportionate increase in LV ejection volume. The regurgitant fraction reenters the LV, producing left ventricular volume overload. The LV compensates via the Frank-Starling mechanism, resulting in a greater ventricular stroke volume. The volume of the regurgitant fraction depends on several factors, including size of the orifice allowing regurgitation and the pressure gradient between the left ventricle and left atrium. This volume also depends on ventricular systolic pressure; therefore, the regurgitant volume increases in situations that increase afterload, such as hypertension or aortic stenosis.
The natural history and time course of mitral regurgitation varies, but mitral regurgitation can develop in 3 distinct stages (ie, acute, chronic compensated, chronic decompensated) that are clinically significant. The stages depend on acuity of onset, regurgitant volume, and compliance of the left atrium.
Acute mitral regurgitation stage
Acute mitral regurgitation causes sudden volume overload of the left atrium and LV. Initially, the undilated left atrium restricts the regurgitant volume at the expense of increase in both left atrial and LV end-diastolic pressures.
Although total ventricular stroke volume increases compared to normal, total forward stroke volume usually decreases, thereby lowering cardiac output. In the acute situation, rapidly increasing left atrial pressure results in elevated pulmonary venous pressure causing pulmonary congestion and, eventually, pulmonary edema (see the image below).
Acute stage of mitral regurgitation (MR). Chronic compensated stage
In this stage, the LV compensates by allowing greater diastolic filling and developing LV enlargement to augment forward stroke volume. More importantly, the left atrium dilates in response to the increased volume. Compensation for the increased volume can occur without resulting in increased pressure in the pulmonary circulation and the right heart. Left atrial compliance decreases the afterload on the LV, whereas LV dilation and hypertrophy increases contractility. These important changes keep the overall afterload on the left heart normal or unchanged. Although the regurgitant fraction may be high, the larger stroke volume compensates, maintaining a nearly normal forward cardiac output (see the image below).
Chronic compensated stage of mitral regurgitation (MR). Chronic decompensated stage
This stage occurs when the LV is unable to sustain adequate forward cardiac output. As LV contractility begins to decrease, end-systolic volume gradually increases, thereby increasing LV end-diastolic pressure. The resulting increased pressure in the left atrium creates increased afterload, which further impairs LV ejection, thereby creating a repeating cycle. Whereas the end-diastolic and end-systolic volumes increase, pulmonary congestion eventually results if the cause of the mitral regurgitation is left untreated. Although the forward LV ejection fraction is reduced compared to the compensated phase, the overall ejection fraction could remain normal because of a large regurgitant flow.
As the degree of mitral regurgitation worsens, the total ejection fraction falls, indicating increasing ventricular dysfunction. Pulmonary hypertension may develop under long-standing increased pulmonary venous pressure, and, ultimately, it can lead to right heart failure (see the image below).
Chronic decompensated stage of mitral regurgitation (MR). Ahmed MI, McGiffin DC, O'Rourke RA, Dell'Italia LJ. Mitral regurgitation. Curr Probl Cardiol. Mar 2009;34(3):93-136. [Medline].
Rahimtoola SH. The mitral valve is a complex structure. Foreword. Curr Probl Cardiol. Mar 2009;34(3):89. [Medline].
Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial. Am Heart J. Apr 2009;157(4):762.e3-10. [Medline].
Pederzolli N, Agostini F, Fiorani V, et al. Postendocarditis mitral valve aneurysm. J Cardiovasc Med (Hagerstown). Mar 2009;10(3):259-60. [Medline].
Carpentier A. Congenital malformations of the mitral valve. In: Stark J, de Laval M, eds. Surgery for Congenital Heart Defects. WB Saunders Co; 1983:467-82.
Little SH, Pirat B, Kumar R, et al. Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. JACC Cardiovasc Imaging. Nov 2008;1(6):695-704. [Medline].
Calafiore AM, Gallina S, Iaco AL, et al. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis. Ann Thorac Surg. Mar 2009;87(3):698-703. [Medline].
Wan CK, Suri RM, Li Z, et al. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary?. J Thorac Cardiovasc Surg. Mar 2009;137(3):635-640.e1. [Medline].
Bernal JM, Gutierrez F, Farinas MC, et al. Use of mitral homograft to support a mechanical valve prosthesis: a feasible solution for recurrent mitral valve dysfunction. J Thorac Cardiovasc Surg. Mar 2009;137(3):762-3. [Medline].
Anderson RH, Wilcox BR. The anatomy of the mitral valve. In: Wells FC, Shapiro LM, eds. Mitral Valve Disease. 2nd ed. Butterworth-Heinemann; 1996:4-13.
Barlow JB. Mitral regurgitation. In: Perspectives on the Mitral Valve. FA Davis Co; 1987:113-31.
Carabello BA. Mitral valve regurgitation. Curr Probl Cardiol. Apr 1998;23(4):202-41. [Medline].
Dunn JM. Porcine valve durability in children. Ann Thorac Surg. Oct 1981;32(4):357-68. [Medline].
Eckberg DL, Gault JH, Bouchard RL, et al. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation. Jun 1973;47(6):1252-9. [Medline].
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. Mar 3 2005;352(9):875-83. [Medline].
Kolibash AJ Jr, Kilman JW, Bush CA, et al. Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse. Am J Cardiol. Oct 1 1986;58(9):762-7. [Medline].
Kon MW, Myerson SG, Moat NE, Pennell DJ. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis. Jul 2004;13(4):600-7. [Medline].
Krivokapich J. Echocardiography in valvular heart disease. Curr Opin Cardiol. Mar 1994;9(2):158-63. [Medline].
Magovern JH, Moore GW, Hutchins GM. Development of the atrioventricular valve region in the human embryo. Anat Rec. Jun 1986;215(2):167-81. [Medline].
Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. Aug 1972;46(2):227-39. [Medline].
Shimoyama H, Sabbah HN, Rosman H, et al. Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. J Am Coll Cardiol. Mar 1 1995;25(3):768-72. [Medline].
Skoularigis J, Sinovich V, Joubert G, Sareli P. Evaluation of the long-term results of mitral valve repair in 254 young patients with rheumatic mitral regurgitation. Circulation. Nov 1994;90(5 Pt 2):II167-74. [Medline].
Tribouilloy C, Shen WF, Leborgne L, et al. Comparative value of Doppler echocardiography and cardiac catheterization for management decision-making in patients with left-sided valvular regurgitation. Eur Heart J. Feb 1996;17(2):272-80. [Medline].

